BCL2 and metabolic dysfunction-associated steatohepatitis: Compared with the control group, the CDHFD significantly activated the protein expression of caspase-3, -8, and -9, and cytochrome C in the liver tissues of NASH rats and inhibited the expression of the anti-apoptotic protein Bcl-2.